Leonard S. Schleifer

2012

In 2012, Leonard S. Schleifer earned a total compensation of $30M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 184% increase compared to previous year.

Compensation breakdown

Bonus$2,300,000
Option Awards$26,630,306
Salary$1,000,000
Other$116,791
Total$30,047,097

Schleifer received $26.6M in option awards, accounting for 88.63% of the total pay in 2012.

Schleifer also received $2.3M in bonus, $1M in salary and $116.8K in other compensation.

Rankings

In 2012, Leonard S. Schleifer's compensation ranked 37th out of 11,378 executives tracked by ExecPay. In other words, Schleifer earned more than 99.7% of executives.

ClassificationRankingPercentile
All
37
out of 11,378
100th
Division
Manufacturing
16
out of 4,204
100th
Major group
Chemicals And Allied Products
3
out of 1,150
100th
Industry group
Drugs
3
out of 888
100th
Industry
Pharmaceutical Preparations
2
out of 669
100th
Source: SEC filing on April 21, 2015.

Schleifer's colleagues

We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2012.

2012

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2012

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2012

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

2012

Robert Terifay

Regeneron Pharmaceuticals

Senior Vice President, Commercial

News

In-depth

You may also like